The world’s biggest food manufacturing firm, Nestle is setting up a unit that would focus on developing personalized nutrition products in order to help prevent or treat health complexities like obesity, heart diseases, diabetes and Alzheimer’s.

Americas’ Nestle’s business Leader, Luis Cantarell will take the role of Chief Executive of Nestle Health Science, as informed by the corporation.

Jean-Marie L’Home, an Analyst at Aurel in Paris said that Nestle could utilize cash from a sale in the previous month so as to finance the research and become a leader in the foods market that targets health needs of the masses.

It could possibly outdo Groupe Danone, which is the leader at the moment.

In the preceding month, Nestle received $28.3 billion from Novartis, with a majority stake in the eye care unit of the Alcon.

He said that in a few years, Nestle would take over the chair of being a new leader.

Medical unit sales for Danone in 2009 were $1.2 billion, and it withdrew its tender with the European Food Safety Authority for its Actimel yogurt drinks’ health claims.

The maker in a statement said that its unit would comprise its present health care nutrition business, which in the previous year saw sales of $1.6 billion.